Carme Pedro

1.3k total citations
27 papers, 342 citations indexed

About

Carme Pedro is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Carme Pedro has authored 27 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 15 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Carme Pedro's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). Carme Pedro is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). Carme Pedro collaborates with scholars based in Spain, Germany and United States. Carme Pedro's co-authors include Lourdes Florensa, Françesc Solé, S Woessner, Magı́ Farré, Sergio Abanades, J Sans-Sabrafén, Ana Rodríguez-Campello, Carlos Besses, Jordi Segura and P. Aguado and has published in prestigious journals such as Blood, Cancer and The American Journal of Surgical Pathology.

In The Last Decade

Carme Pedro

27 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carme Pedro Spain 12 185 151 84 62 59 27 342
BC Wolf United States 8 145 0.8× 234 1.5× 99 1.2× 73 1.2× 49 0.8× 9 412
Nadia M T Roodenrijs Netherlands 10 133 0.7× 91 0.6× 59 0.7× 19 0.3× 29 0.5× 13 423
Özden Vural Türkiye 11 110 0.6× 46 0.3× 35 0.4× 63 1.0× 59 1.0× 20 314
V. Leguy‐Seguin France 11 134 0.7× 88 0.6× 50 0.6× 19 0.3× 25 0.4× 28 424
Carmine D’Urzo Italy 8 164 0.9× 151 1.0× 30 0.4× 46 0.7× 270 4.6× 15 505
Federica Defendi France 12 54 0.3× 163 1.1× 62 0.7× 25 0.4× 49 0.8× 26 320
Hedley Griffiths Australia 12 127 0.7× 77 0.5× 47 0.6× 15 0.2× 18 0.3× 31 304
C. F. Lucas United Kingdom 5 178 1.0× 50 0.3× 17 0.2× 35 0.6× 31 0.5× 7 321
S Wassenberg Germany 6 126 0.7× 36 0.2× 39 0.5× 20 0.3× 96 1.6× 8 408
Coralie Derrieux France 9 52 0.3× 50 0.3× 128 1.5× 80 1.3× 34 0.6× 16 297

Countries citing papers authored by Carme Pedro

Since Specialization
Citations

This map shows the geographic impact of Carme Pedro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carme Pedro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carme Pedro more than expected).

Fields of papers citing papers by Carme Pedro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carme Pedro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carme Pedro. The network helps show where Carme Pedro may publish in the future.

Co-authorship network of co-authors of Carme Pedro

This figure shows the co-authorship network connecting the top 25 collaborators of Carme Pedro. A scholar is included among the top collaborators of Carme Pedro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carme Pedro. Carme Pedro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bussaglia, Elena, Marta Pratcorona, Laura San‐Segundo, et al.. (2020). Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies). Annals of Hematology. 99(4). 765–772. 5 indexed citations
2.
Reverter‐Branchat, Gemma, et al.. (2018). Detection of erythropoiesis‐stimulating agents in a single dried blood spot. Drug Testing and Analysis. 10(10). 1496–1507. 27 indexed citations
3.
Arenillas, Leonor, Lourdes Florensa, Anna Puiggros, et al.. (2018). Diagnostic Utility of Flow Cytometric Immunophenotyping in Chronic Myelomonocytic Leukemia. Blood. 132(Supplement 1). 5526–5526. 1 indexed citations
6.
Ramos, Fernando, Carme Pedro, Mar Tormo, et al.. (2016). Impact of anaemia on health-related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL study. European Journal of Cancer Care. 26(6). e12426–e12426. 2 indexed citations
9.
Santamaría, Carlos, Fernando Ramos, Noemí Puig, et al.. (2012). Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival. Annals of Hematology. 91(12). 1887–1895. 12 indexed citations
10.
Martínez‐Avilés, Luz, Alberto Álvarez‐Larrán, Carles Besses, et al.. (2012). Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia. Annals of Hematology. 91(10). 1555–1562. 6 indexed citations
11.
Florensa, Lourdes, Elisa Luño, Carmen Sanzo, et al.. (2012). Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes. British Journal of Haematology. 159(3). 311–321. 17 indexed citations
12.
González‐Porras, José Ramón, Esperanza Such, Benet Nomdedeu, et al.. (2011). Prognostic impact of severe thrombocytopenia in low‐risk myelodysplastic syndrome. Cancer. 117(24). 5529–5537. 39 indexed citations
13.
Mercadal, Santiago, Armando López‐Guillermo, Javier Briones, et al.. (2006). Is There a Role for Autologous Stem-Cell Transplantation (ASCT) in Peripheral T-Cell Lymphoma (PTCL)? Final Results of a Prospective Phase II Study from the GELCAB.. Blood. 108(11). 3070–3070. 4 indexed citations
14.
Pijuán, Lara, Luís Vicioso, Beatríz Bellosillo, et al.. (2005). CD20-Negative T-Cell-Rich B-Cell Lymphoma as a Progression of a Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Treated With Rituximab. The American Journal of Surgical Pathology. 29(10). 1399–1403. 13 indexed citations
15.
Espinet, Blanca, Françesc Solé, Carme Pedro, et al.. (2005). Clonal proliferation of cyclin D1–positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?. Human Pathology. 36(11). 1232–1237. 33 indexed citations
16.
Alameda, Francesc, et al.. (2003). Primary epidural lymphoma. Journal of Neurosurgery Spine. 98(2). 215–217. 9 indexed citations
17.
Pedro, Carme, et al.. (2002). Spurious thrombocytosis associated with cryoglobulinaemia: a case report.. PubMed. 87(8). ELT39–ELT39. 1 indexed citations
18.
Solé, Françesc, S Woessner, Lourdes Florensa, et al.. (1999). Cytogenetic Findings in Five Patients with Hairy Cell Leukemia. Cancer Genetics and Cytogenetics. 110(1). 41–43. 7 indexed citations
19.
García‐Patos, Vicente, Carme Pedro, Christian A. Sander, et al.. (1998). Kaposi’s Sarcoma in a Patient with Erythroblastopenia and Thymoma: Reactivation after Topical Corticosteroids. Dermatology. 197(3). 264–267. 12 indexed citations
20.
Florensa, Lourdes, et al.. (1989). Circulating erythroid and megakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia. European Journal Of Haematology. 43(5). 417–422. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026